Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market to Grow at a CAGR of 4.4% to reach US$ 194,604.51 thousand from 2020 to 2028

The SIBO diagnostics market was valued at US$ 138,324.23 thousand in 2020, and it is projected to reach US$ 194,604.51 thousand by 2028; it is expected to grow at a CAGR of 4.4% from 2021 to 2028.

Small intestinal bacterial overgrowth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.

The SIBO diagnostics market is segmented on the basis of diagnosis, type, and geography. Based on geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the SIBO diagnostics market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID-19 impact analysis across all the regions. It is estimated that the market is likely to have slower growth rate during the forecast period owing to the restricted health services and lockdown situation caused by COVID-19 pandemic.

Lucrative Regions for SIBO Diagnostics Market

Market Insights

Increasing Prevalence of Irritable Bowel Syndrome (IBS) and SIBO

Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. The incidences of IBS are increasing at a significant rate across the world. According to a research article, ‘Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study’ published by Elsevier Inc. in 2021, most countries have a prevalence rate of 2–6%. Countries such as Japan, China, Russia, South Africa, and the US have a prevalence rate of 2.2%, 2.3%, 5.9%, 5.9%, and 5.3%, respectively. The increasing prevalence of IBS across the world is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS.

Likewise, SIBO shows similar symptoms to IBS. Technological developments have now allowed the diagnosis of SIBO while diagnosing IBS. Therefore, the prevalence of SIBO is widely understood and reported worldwide. For instance, according to an article, ’Small Intestinal Bacterial Overgrowth: A Case-Based Review’ published in the Journal of Patient-Centered Research and Reviews (JPCRR) in November 2015, 30–85% of adult patients with IBS are likely to develop SIBO. Similarly, according to the recent data published in 2020 by the American College of Gastroenterology, ~78% of IBS patients are living with SBIO; hence, it is a predominantly evaluated condition. It is, therefore, estimated that the prevalence of IBS and SIBO will grow significantly in the near future, leading to the increasing diagnosis and eventual market growth.

Diagnosis-Based Insights

Based on diagnosis, the SIBO diagnostics market is segmented into breath testing, small intestine aspirate and fluid culture test, blood test, and others. In 2020, the breath testing segment held the largest share of the market, and is also expected to grow at the fastest rate in the coming years. The growth is attributed due to its advantages, such as non-invasive, patient-friendly, simplicity, and low-cost

Global SIBO Diagnostics Market, by Diagnosis – 2020 & 2028

Type-Based Insights

Based on type, the SIBO diagnostics market is segmented into hydrogen-predominant SIBO, methane-predominant SIBO, and recurrent SIBO. In 2020, the hydrogen-predominant SIBO segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Organic strategies such as product launch, are commonly adopted by the market players to meet the changing customer demand and maintain their improved services. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc., announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type Irritable Bowel Syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.

By Diagnostics

• Breath Testing
  • 14C Xylose Breath Test
  • Hydrogen Breath Tests
  • 14C Glycocholic Acid Breath Test
  • Malabsorption Tests
• Small Intestine Aspirate and Fluid Culture Test
• Blood Test
• Others

By Type

• Hydrogen-predominant SIBO
• Methane-predominant SIBO
• Recurrent SIBO

By Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Genova Diagnostics
• SIBO Diagnostics
• Commonwealth Diagnostics International
• Aerodiagnostics, LLC
• SIBOTest
• Metabolic Solutions, Inc.
• Pivotal Diagnostics
• DirectLabs, LLC
• Vibrant Wellness
• Health Associates Medical Group

Report Scope

Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Regional Insights

The regional trends and factors influencing the Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Scope

Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Published Report - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market are:

1. Genova Diagnostics
2. SIBO Diagnostics
3. Commonwealth Diagnostics International
4. Aerodiagnostics, LLC
5. SIBOTest

Disclaimer: The companies listed above are not ranked in any particular order.